PRP (platelet-rich plasma) injection

Platelet-rich plasma (PRP) therapy concentrates autologous platelets to levels well above baseline whole blood. Those platelets carry growth factors—including platelet-derived growth factor (PDGF) and transforming growth factor (TGF)—that are thought to accelerate soft-tissue and bone repair. In orthopedics and sports medicine, PRP injections are used for conditions such as knee osteoarthritis, lateral epicondylitis, Achilles tendinopathy, plantar fasciitis, and rotator cuff pathology, as well as adjunctively in surgeries including ACL reconstruction and spinal fusion.

From a coding standpoint, CPT Category III code 0232T is the single reporting unit for the non-wound PRP injection encounter. It bundles blood collection, centrifugation and preparation, imaging guidance (when used), and the injection itself. Because it is a Category III code, Medicare assigns it zero relative value units (RVUs), and most Medicare Administrative Contractors (MACs) do not reimburse it. Commercial payer behavior varies widely; Workers' Compensation programs in some states have been among the more consistent payers. Prior authorization is frequently required, and coverage denials are common because many payers—including Blue Shield of California and UnitedHealthcare Medicare Advantage—classify all orthopedic PRP applications as investigational.

Documentation must establish medical necessity clearly: conservative therapies tried and failed, the specific anatomic site, imaging or clinical findings supporting the diagnosis, and the rationale for PRP over other interventions. When PRP is placed into an operative field during a concurrent surgical procedure, it is not separately reportable; it is considered inclusive to the operative code. Code 0232T is only reported when PRP is the sole, distinct procedure performed at a separate patient encounter.

Using the wrong code—most commonly billing 0232T's component services as trigger-point injections (e.g., 20552–20553) or joint injections (20600–20610)—constitutes a misrepresentation of the actual service and can trigger claim denial, payer audit, or fraud and abuse scrutiny. Because 0232T carries zero Medicare RVUs, failing to verify payer-specific coverage and obtain prior authorization before the procedure almost guarantees non-payment; the financial burden then falls on the patient or the practice, and a retroactive appeal is rarely successful. Equally important: if PRP is administered during surgery, billing 0232T separately violates bundling rules and will be denied or recouped.